Teratology for the obstetrician: current status.
The importance of teratology to obstetrician and patient has been demonstrated by the occurrence of a number of "mini-epidemics" of anomalies caused by drug ingestion during pregnancy. The scope of the problem is discussed, and drugs are reviewed by therapeutic classification for their teratologic potential.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002996:Clomiphene / Q000009:adverse effects; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D011247:Pregnancy; D011372:Progestins / Q000009:adverse effects; D011619:Psychotropic Drugs / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D011372:Progestins; D011619:Psychotropic Drugs; D002996:Clomiphene; D008238:Lysergic Acid Diethylamide